Luminary Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-05.
Luminary Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 5, 2025. The filing reports $1.41M sold. Its industry group is Biotechnology. It names Jeff Liter (Executive Officer, Director, Promoter), John Wells (Director), James Haymaker (Director, Promoter) (SEC Form D, November 5, 2025).
Is this your company?
Sell to companies like Luminary Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Luminary Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Luminary Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Minnesota, filed within 90 days of this one, largest first.
Get an email when Luminary Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Luminary Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Luminary Therapeutics, Inc. →Get the full cited report on Luminary Therapeutics, Inc.
What the filing shows about Luminary Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Luminary Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Luminary Therapeutics, Inc.'s address as 1200 Washington Avenue South, Suite 260, Minneapolis, MN 55415.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Luminary Therapeutics, Inc. See pricing
Luminary Therapeutics, Inc. is a registered filer with the SEC (CIK 1793860) and has filed since 2023-01-11. 3 filings are on record, the latest on 2025-11-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Luminary Therapeutics, Inc.'s Form D of 2025-11-05 names Jeff Liter, John Wells, James Haymaker and 4 more as its officers, directors or promoters.
Its new offerings report $8.74M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $1.41M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Jeff Liter is named as Executive Officer and Director and Promoter on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
John Wells is named as Director on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
James Haymaker is named as Director and Promoter on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
Tracey Lodie is named as Director on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
Mark Chance is named as Director on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
Jeff Ross is named as Director on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
Branden Moriarity is named as Director on the Form D that Luminary Therapeutics, Inc. filed with the SEC on 5 November 2025, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2025-11-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Luminary Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Luminary Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Luminary Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Luminary Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Luminary Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Luminary Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Minneapolis-St. Paul
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/luminary-therapeutics-inc-form-d-25000001